A utopsy studies show that acute coronary events are a frequent cause of sudden death in patients with ischemic cardiomyopathy. 1 These findings suggest that patients with ICM are at risk for recurrent myocardial ischemia. Despite this susceptibility for secondary cardiovascular events, the expression of innate cardiac protective molecules in the hearts of patients with ischemic cardiomyopathy is not known.
KCNJ11 Protects Against Nitro-Oxidative Stress thereby adjusting the intracellular ionic balance during periods of increased cardiac stress. 4, 5 In the heart, the inward rectifying K + channel, Kir6.2 associates with regulatory sulfonylurea SUR2A receptor subunits to form the traditional sarcolemmal K ATP channel (sarcK ATP ). 5 The fact that genetic disruption of the kcnj11 gene that encodes the Kir6.2 subunit negates that the cardiac protective phenomenon of ischemic preconditioning demonstrates the critical role of the kcnj11 gene in cardiac homeostasis. [6] [7] [8] Thus, loss or decrease of KCNJ11 gene expression in humans would be predicted to increase the susceptibility to myocardial injury. Since the discovery of K ATP channels, it has been proposed that K ATP channel activity provides metabolism-sensing feedback that shortens the cardiac action potential duration thereby decreasing calcium influx through the L-Type calcium channel. 2 Deficiency in sarcK ATP channel activity results in dysfunctional intracellular calcium handling with myocardial stress. [9] [10] [11] [12] However, the mechanisms responsible for this calcium mishandling are incompletely resolved. The L-type calcium channel, phospholamban, sarcoendoplasmic reticulum Ca 2+ -ATPase (SERCA2a), the ryanodine receptor, and the sodium-calcium exchanger cooperatively regulate cytosolic calcium levels in cardiomyocytes. Phospholamban phosphorylation regulates SERCA2a activity, controlling the reuptake of calcium into the sarcoplasmic reticulum. 13, 14 Here, we demonstrate decreased KCJN11 gene transcript levels in patients with ischemic cardiomyopathy. Similarly, in mice, the kcnj11 gene transcript level is reduced in theremote (noninjured, noninfarct adjacent) myocardium after a myocardial infarction. The functional effect of ablation of the kcnj11 gene expression in mice increased ischemia-reperfusioninduced nitro-oxidative stress and impaired in vivo diastolic cardiac function associated with differential phospholamban phosphorylation and 3-nitrotyrosine modification of SERCA2a.
Materials and Methods
Detailed Materials and Methods are described in the Data Supplement.
Human Left Ventricular RNAseq Analysis
The Vanderbilt University Institutional Review Board approved the human study, and it conforms to the principles outlined in the Declaration of Helsinki. Left ventricular tissue was obtained from 7 end-stage ischemic cardiomyopathy hearts and 7 normal hearts not used for transplantation.
RNA Extraction
RNA from the human and murine heart tissues was prepared using miRNeasy Mini Kit (Qiagen Cat No. 217004). We measured kcnj11 transcript levels rather than protein as previous studies have shown that Kir6.2 protein levels and kcnj11 transcript levels correlate. 15, 16 
RNA-Seq
The RNA libraries were constructed using the Illumina TruSeq Stranded Total RNA with Ribo-Zero Gold. Samples were sequenced on the Illumina HiSeq 2500 using v3 SBS chemistry. Libraries were sequenced on a Single-Read 50 run at 30M PF reads per sample.
Computational Analysis of RNA-Seq Data
The sequence files were then aligned to human assembly build hg19 using the Tophat2 splice junction mapper (http://ccb.jhu.edu/ software/tophat/index.shtml). Transcripts were assembled, and differential expression analysis was performed, with Cufflinks (http:// cole-trapnell-lab.github.io/cufflinks/). A second independent analysis was also performed using Partek Flow software, version 3.0 (Partek Inc., St. Louis, MO; www.partek.com).
Gene Functional Annotation
Functional analysis of differentially expressed genes was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID, version 6.7).
Mice
The investigation conformed to the Guidelines for the Care and Use of Laboratory Animals of the National Institutes of Health and was approved by the Vanderbilt University and The Ohio State University Institutional Animal Care and Use Committees. Wild-type (WT) littermate control mice or kcnj11-knockout (kcnj11-null) in a C57BL/6 background were used in this study. We examined differences in male mice because we have previously determined that female mice with kcnj11 knockout are more susceptible to ischemic injury. 12 Mice devoid of kcnj11 expression have been previously shown to have normal cardiac and vascular development and normal basal cardiac function. 
Ex Vivo Myocardial Ischemia-Reperfusion Injury
Hearts were perfused using a Langendorff system.
17

Dihydroethidium Fluorescence
Superoxide anion generation was determined using dihydroethidium fluorescence.
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In Vivo Myocardial Infarction
The in vivo coronary artery ligation model was performed as previously described.
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In Vivo Myocardial Ischemia-Reperfusion With Hemodynamic Monitoring
The myocardial ischemia-reperfusion mouse model was performed as described previously.
17,19 A 1.4F Millar Mikro-Tip catheter (SPR-839; Millar Instruments, Houston, TX) was inserted via the right carotid artery into the left ventricle to monitor left ventricular hemodynamics.
Echocardiographic Measurements
Two-dimensional echocardiographic views of the midventricular short axis were obtained at the level of the papillary muscle tips below the mitral valve.
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Immunoblot and Immunoprecipitation Analysis
Immunoblots and SERCA2a immunoprecipitation were performed as previously described. 17 
Statistical Analysis
Results are expressed as quartiles and median (mean±SE for hemodynamic data). For comparison between 2 groups, GraphPad 6.0 was used. Significance was determined by unpaired Student t test with Welch adjustment. For comparison of the temporal in vivo hemodynamic data, a generalized least squares model with an AR1 correlation structure to take into account the correlation within each subject was fit for each of our outcome variables. These analyses were done using R version 3.1.2. 23 For interpretation and discussion, the authors used a threshold of P<0.05 to indicate evidence of a significant effect. However, in accordance with the recent American Statistical Association statement on statistical significance and P values, we provide P values so the readers can judge the significance of the reported effects.
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Results
KCNJ11 Transcript Level Is Decreased in Human Ischemic Cardiomyopathy
RNAseq analysis was performed on 7 hearts from patients with ischemic cardiomyopathy, procured at the time of transplantation, and 7 control hearts procured from donors that did not match for transplantation. The clinical data for each group are provided in the Figure 1B ). Hierarchical clustering revealed distinct patterns between the ICM and control samples (Figure 1C) . Adjustment for age did not alter the data ( Figure I in the Data Supplement).
Gene ontology analysis revealed significant differences in the transcript levels of >40 ion transport genes, >40 oxidation-reduction genes, and >10 potassium-handling genes ( Figure 1D ). Analysis of the expression of the cardiac protective KCNJ11 gene by RNAseq analysis revealed a >2 fold decrease in transcript levels in the ICM hearts compared with control hearts ( Figure 1E ). However, the transcript levels of ABCC8 (SUR2A) and ABCC9 (SUR2B), which encode the sulfonylurea receptor component of K ATP channels, did not differ between control and ICM patients (not shown).
Downregulation of kcnj11 Transcripts After Myocardial Infarction in Mice
WT mice were subjected to coronary artery ligation to determine whether kcnj11 expression is altered after a myocardial infarction. Compared with the baseline assessment, at 7 and 28 days after myocardial infarction, the left ventricular internal diastolic ( Figure 2A ; P<0.001 day 7 and day 28) and systolic ( Figure 2B ; P=0.006 day 7; P<0.001 day 28) diameters significantly increased. Fractional shortening was significantly reduced at both 7 and 28 days after myocardial infarction (Figure 2C ; P<0.001 day 7 and day 28). There was no difference in kcnj11 transcript levels by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) in control (no surgery) and sham-treated mice (data not shown). However, there was a reduction in the kcnj11 transcript level in the remote (noninjured, noninfarct adjacent) myocardium in WT mice at both day 7 ( Figure 2D ; P=0.015) and day 28 (P=0.0506).
Lack of kcnj11 Expression Exacerbates In Vivo Cardiac Recovery
Next, we examined the in vivo functional consequences of lack of kcnj11 expression after ischemia-reperfusion injury. Mice underwent brief in vivo left coronary artery ischemia (20 minutes) followed by reperfusion while assessing cardiac function with continuous ventricular pressure measurement. This approach allowed us to examine not only an overall genotype effect but also the effect of the genotype on the hemodynamic response during the ischemic or reperfusion phases.
There were no differences between the 2 groups on age, body weight, heart weight, or body weight-to-heart weight ratio (Table II in the Data Supplement). There was not a significant interaction between genotype and ischemia or reperfusion for heart rate (P=0.11). However, the heart rate response was overall significantly lower in kcnj11-null mice (P<0.001; Figure 3A ).
The maximum left ventricular pressure revealed no significant interaction between genotype and ischemia or reperfusion (P=0.29). However, overall there was a trend toward a higher maximal systolic pressure in WT mice (P=0.09; Figure 3B , top). In contrast, there was a significant interaction (P=0.031) between genotype and ischemia or reperfusion for left ventricular end-diastolic pressure, a clinically used measurement of diastolic function. 25, 26 Left ventricular end-diastolic pressure was significantly increased during the reperfusion phase in kcnj11-null mice compared with that in WT mice (P=0.56 for ischemia; P<0.001 for reperfusion comparison; Figure 3B , bottom).
Comparison of the rate-pressure product (heart rate×systolic blood pressure) showed a nearly significant interaction (P=0.0504 for interaction term) between genotype and ischemia or reperfusion in kcnj11-null mice compared with WT mice. The rate-pressure product response in kcnj11-null mice was more impaired during reperfusion compared with WT mice (P=0.33 for ischemia, P<0.001 for reperfusion comparison; Figure 3C ).
Analysis of cardiac contractility, measured as the rate of left ventricular pressure rise (dP/dt max ), demonstrated a significant interaction of genotype with ischemia and reperfusion between WT and kcnj11-null mice (P=0.043 for interaction term). Although there was no difference Figure 1 . RNAseq analysis of control vs ischemic cardiomyopathic (ICM) left ventricle. RNA was isolated from left ventricular heart samples from patients with end-stage ICM (n=7) or normal hearts (n=7) and subjected to RNAseq analysis. A, Plot of significance vs foldchange in all transcripts detected. B, Principal component analysis of ICM and control data. C, Hierarchical clustering of RNA transcript reads per kilobase per million mapped reads for genes with significant differential expression (fold difference >1.5, multiple hypothesiscorrected P value <0.05) between control and ICM samples using Partek Genomics Suite with average linkage and Euclidean distance measures. Bright red, bright green, and black indicate the highest, lowest, and median normalized reads, respectively. Vertical dendrograms represent the individual patient samples, of which there are 7 replicates for each group. D, Gene counts of significantly differing transcript levels between ICM and control hearts within gene ontology (GO) terms. E, Fold differences in fundamental potassium channel levels found in the potassium ion transport GO cluster. KCNJ11 Protects Against Nitro-Oxidative Stress detected during ischemia, there was a significant reduction in the dP/dt max during reperfusion in kcnj11-null mice compared with WT mice (P<0.001 for reperfusion comparison; Figure 3D , top). In addition, comparison of diastolic function, measured as the rate of left ventricular relaxation (dP/dt min ), revealed a significant interaction between genotype and ischemia or reperfusion (P=0.001 for interaction term; Figure 3D , lower) between WT and kcnj11-null mice. Although no difference was detected between kcnj11-null mice and WT mice during ischemia, there was a significant reduction in the dP/dt min in kcnj11-null mice during reperfusion (P<0.001 for reperfusion comparison; Figure 3D , lower). Together, these data demonstrate for the first time that kcnj11-null mice have more severe in vivo diastolic dysfunction on reperfusion.
Kcnj11 Knockout Does Not Alter Basal CalciumHandling Proteins
To determine whether compensatory changes in kcnj11-null mice contributed to the hemodynamic effects observed, we measured basal calcium current density. There was no difference between WT and kcnj11-null hearts in basal L-Type calcium current density ( Figure IIA 
Phospholamban Phosphorylation Increases in kcnj11-Null Hearts
Phospholamban phosphorylation is a critical regulator of calcium reuptake and, therefore, diastolic function. Unphosphorylated phospholamban interacts with SERCA2a, thereby inhibiting calcium reuptake, whereas phosphorylation of Serine-16 (Ser16) or Threonine-17 (Thr17) of phospholamban increases SERCA activity.
27-29 Therefore, we examined whether differences in the level of phospholamban Ser16 and Thr17 phosphorylation occurred in kcnj11-null hearts. At baseline, the levels of total phospholamban, phospholamban Ser16 or phospholamban Thr17 phosphorylation in WT and kcnj11-null hearts did not differ ( Figure III in the Data Supplement ). After myocardial ischemia-reperfusion injury, there was no difference in the total level of phospholamban between WT and kcnj11-null hearts ( Figure 4A) . However, at 15 minutes of reperfusion, there was a significant increase in the ratio of phospholamban Ser16 phosphorylation to total phospholamban levels in kcnj11-null mice compared with WT mice (Figure 4B ; P=0.031). In addition, there was a significant decrease in the ratio of phospholamban Thr17 phosphorylation to total phospholamban levels in kcnj11-null mice compared with WT mice (Figure 4C ; P=0.039). However, by 60 minutes of reperfusion, the ratio of phospholamban Ser16 phosphorylation:total phospholamban levels in kcnj11-null mice remained elevated compared with WT mice (Figure 4D ; P=0.003). In contrast, there was no significant difference in the ratio of phospholamban Thr17 phosphorylation to total phospholamban levels in kcnj11-null mice compared with WT mice at 60 minutes of reperfusion ( Figure 4E; P=0.54 ). These data demonstrate differential phosphorylation of the key SERCA2a regulating protein, phospholamban, in kcnj11-null mice.
Loss of kcnj11 Expression Accentuates Reactive Oxygen Species Generation
Given that difference in phospholamban phosphorylation did not completely explain the effects on cardiac function observed in kcnj11 mice in response to IR injury, we measured the effect of kcnj11 gene ablation on reactive oxygen species generation. Isolated WT and kcnj11-null hearts underwent 30 minutes of global ischemia and 60 minutes of reperfusion. In agreement with previous work, infarct size was comparable between WT and kcnj11-null hearts ( Figure 5A ; P=0.10). 6 However, dihydroethidium staining revealed increased ROS generation in kcnj11-null hearts compared with WT hearts (P=0.048; Figure 5B ). These data demonstrate for the first time that ROS generation is increased in the absence of kcnj11 expression in the heart.
3-Nitrotyrosine Modification of SERCA Is Increased in kcnj11 Deficient Hearts After Myocardial Ischemia-Reperfusion
With the increase in ROS observed in kcnj11-null mice (Figure 6A) , we postulated that irreversible peroxynitrite-mediated modification of the critical calcium-handling protein SERCA2a might contribute to the impaired diastolic dysfunction observed.
17 3NT-modified SERCA is not functional. [30] [31] [32] At baseline, both WT and kcnj11-null mice expressed comparable total SERCA2a and 3-NT-modified SERCA2a levels ( Figure IV in the Data Supplement). After myocardial ischemia-reperfusion injury, both WT and kcnj11-null mice expressed comparable total SERCA2a levels ( Figure 6B ; P=0.15). Both WT and kcnj11-null mice expressed comparable total SERCA2a levels ( Figure 6B ; P=0.15). However, after in vivo ischemia and 60 minutes of reperfusion peroxynitritemediated 3-nitrotyrosinylation of SERCA2a was significantly increased in kcnj11-null mice compared with WT mice (Figure 6D ; P=0.031). These data suggest that 3NT modification of SERCA2a is an additional mechanism that contributes to the calcium overload observed in kcnj11-null mice.
Discussion
The current study demonstrates that in human hearts with end-stage ischemic cardiomyopathy, KCNJ11 transcript levels are diminished. Similarly, in mice, decreased expression of kcnj11 occurred after a myocardial infarction. The functional ramification of loss of kcnj11 expression in mice is an increased susceptibility to ischemia-reperfusion-induced cardiac diastolic dysfunction associated with an increased ROS generation and increased peroxynitrite-mediated modification of the critical calcium-handling protein SERCA2a. Together, these data suggest a mechanism whereby the ischemic cardiomyopathic heart is more susceptible to ischemia-induced cardiac dysfunction. Given that in an autopsy study, >50% of patients with ICM were found to have acute coronary findings, 1 whether the decrease in KCNJ11 expression conveys a greater risk for ischemia-reperfusion-induced diastolic dysfunction is an intriguing hypothesis. Although KCNJ11 transcript levels in patients with heart failure have been reported, the patient population in the study was not specifically ICM, but rather a group with mixed causes of heart failure. 33 The current study specifically compared known ICM patient samples with control patient samples, thereby definitively establishing that KCNJ11 transcript level is decreased in ICM. Previous work has suggested K ATP channel expression and function is decreased with age in animal models 34, 35 ; however, this was predominantly because of a decrease in SUR2A gene expression. 34 We did not find a difference in the level of SUR2A transcript levels between control and ICM patients despite the observed age difference between the groups; patients with ICM were 14 years older than the control group. A decrease in the expression of the KCNJ11 subunit of the cardiac protective K ATP channel in ICM patients has not been previously appreciated. Furthermore, although differences in human K ATP channel activity could not be examined in our samples, there may also be deficits in K ATP channel function in ICM hearts as suggested by findings in a nonischemic cardiomyopathy mouse model 36 and aged cardiomyocytes. 35 Future studies on isolated human cardiomyocytes are needed to examine this possibility. Our novel finding of decreased kcnj11 transcript expression in the remote myocardium after myocardial infarction also suggests that our observation in humans is not the effect of comparing scarred versus normal tissue. Furthermore, our data suggest that dynamic changes in kcnj11 expression occur in the stressed myocardium of mice. Glucocorticoids, which are increased with the physiological stress of myocardial infarction, downregulate kcnj11 transcript and protein levels. 37 Additional studies are required to decipher the stimulus responsible for the downregulation of kcnj11 expression after myocardial infarction. Previous work has demonstrated that K ATP channels are critical to the energetic adaptation to exercise-induced stress in mice. 38 In vivo, we observed chronotropic insufficiency in Kir6.2-null mice with the stress of myocardial ischemia and reperfusion. Interestingly, in patients with heart failure, recent data suggest that the lack of a chronotropic response with exercise associates with the E23K mutation in the Kir6.2 subunit. 39 Thus, the decrease in KCNJ11 expression in ICM hearts may have multiple functional consequences in humans.
Cytosolic calcium levels are tightly controlled in the heart. Indeed, we have previously shown that the kcnj11-deficient heart is predisposed to calcium overload with stress. 12 With myocardial reperfusion, increased superoxide and nitric oxide drive the formation of peroxynitrite. 40 After ischemia-reperfusion injury, reactive oxygen species and reactive nitrogen species (ROS/RNS) generation results in oxidative and peroxynitrite-mediated modification of key proteins involved in regulation of cardiomyocyte energetics and calcium handling including the L-type Ca 2+ channel, the ryanodine receptor, and SERCA2a. 17, 41, 42 With myocardial reperfusion, increased superoxide and nitric oxide drive the formation of peroxynitrite. 40, 43 Peroxynitrite alters protein structure and function by irreversible nitration of tyrosine residues and cysteine oxidation. 44, 45 Nitrotyrosine is a distinct molecular fingerprint for the presence of peroxynitrite, providing an indication of the level of nitro-oxidative stress. 46 Tyrosine nitration of SERCA2a results in a decrease in SERCA activity 32, 47 and increases the time to half relaxation in cardiomyocytes. 32 Indeed, previous studies in mice have suggested that abnormal calcium handling because of decreased SERCA activity contributes to cardiomyocyte contractile dysfunction. [48] [49] [50] Preserved SERCA2a/ phospholamban-mediated resequestration of cytosolic Ca 2+ into the sarcoplasmic reticulum is necessary for normal myocardial relaxation. 50 Under normal conditions, phospholamban is hypophosphorylated and interacts with SERCA2a to lower the uptake of Ca 2+ by SERCA. [50] [51] [52] Phospholamban is phosphorylated in response to increased cardiac demand. [53] [54] [55] With phosphorylation of phospholamban at Ser16 by protein kinase A, or protein kinase G, the phospholamban/SERCA interaction is reduced, and SERCA-mediated Ca 2+ uptake into the sarcoplasmic reticulum increases. [27] [28] [29] 50, 56 Phosphorylation of Thr17 by Ca 2+ /calmodulin-dependent protein kinase II attenuates impaired relaxation that occurs with reperfusion. 57 The finding that phospholamban phosphorylation at Ser16 is increased in kcnj11-null mice suggests that a compensatory response occurs to attempt to increase SERCA2a activity and preserve calcium homeostasis in kcnj11-nulll mice. However, the decreased phosphorylation of phospholamban at Thr17 suggests that calmodulin-dependent protein kinase II activation is delayed in kcnj11-null mice compared with WT mice, thereby contributing to the observed diastolic dysfunction during early reperfusion. Together, the current findings suggest that kcnj11 gene expression preserves phospholamban/ SERCA2a interactions to reduce calcium mishandling and diastolic dysfunction after ischemia-reperfusion injury. Based on previous work and the current data, we postulate that an initial increase in calcium overload in kcnj11-deficient mice results in increased ROS generation. ROS-generated RNS then drives further calcium overload via 3-NT modification of SERCA2a, thereby creating a detrimental cycle that contributes to the increased susceptibility to injury observed in kcnj11-deficient mice. Phospholamban phosphorylation increases as a compensatory response to preserve residual SERCA2a activity and cardiac function. Additional studies will examine the sequence of events that lead to the impaired cardiac recovery in kcnj11-deficient hearts.
Study Limitations and Future Directions
Several limitations to the study require acknowledgment. The study used WT and germline knockouts of kcnj11. Currently, mice with cardiac-specific ablation of the kcnj11 gene expression are not available for our studies. Future directions would include examining cardiac-specific Kir6.2 knockout mice and examining mice with heterozygote knockouts of kcnj11. The present study did not identify ROS or RNS species in human cardiac tissue. The full repertoire of oxidative species that were increased in response to ischemiareperfusion injury in kcnj11-null mice was not elucidated.
We also recognize that the 3-NT SERCA2a modifications observed and the effect on cardiac function are correlative. Future investigations into cause and effect will require the generation of genetically modified mouse models targeting the modified SERCA2a residues after precise mapping. Additional studies are also examining the effect of kcnj11 ablation on myocardial remodeling after infarction. In our human cardiac tissue analysis, there were 7 samples per group; therefore, it is possible that mild or moderate differences in gene transcript levels may not have been detected. However, despite the small number of samples, robust changes in the transcriptome were found.
Conclusions
We demonstrate diminished KCNJ11 transcript expression in humans with end-stage ischemic cardiomyopathy. We also demonstrate decreased kcnj11 transcript levels in the remote myocardium of mice after a myocardial infarction. Loss of kcnj11 expression results in increased postischemia-reperfusion diastolic dysfunction associated with increased nitro-oxidative modification SERCA2a and differential phospholamban -ATPase (SERCA2a) acutely increases after in vivo myocardial ischemia-reperfusion injury in kcnj11-deficient hearts. Wild-type (WT; n=4) or kcnj11-null (n=4) mice were subjected to 20 min of left coronary artery ligation-induced ischemia and 60 min of reperfusion. Myocardial lysates were processed, subjected to immunoprecipitation with anti-SERCA2a polyclonal antibody. After electrophoresis and transfer of the samples, detection was achieved with (A), an anti-3-nitrotyrosine (3-NT) antibody for quantitating modification, then (B), anti-SERCA2a polyclonal antibody for total SERCA2a quantitation and (C), an anti-GAPDH antibody for normalization. D, Quantitation of the level of 3-NT-modified SERCA2a/total SERCA2a in WT vs kcnj11-null hearts. Box plots with median are graphed. P values obtained from t test with Welch correction. Difference between means: 0.46±0.131; 95% confidence interval: 0.072 to 0.847. KCNJ11 Protects Against Nitro-Oxidative Stress phosphorylation. Based on these findings, we speculate that decreased expression of KCNJ11 in humans with ischemic cardiomyopathy may contribute to an increased susceptibility to subsequent ischemia-reperfusion injury and diastolic dysfunction.
